(CercleFinance.com) – Deep Track Biotechnology Master Fund Ltd, acting on behalf of the funds it manages, declared to the AMF that it crossed upwards, on September 7, the threshold of 5% of the capital of Abivax , due to an off-market acquisition of shares.
The declarant specified that he held, on behalf of said funds, 1,126,000 Abivax shares representing the same number of voting rights, ie 5.05% of the capital and 3.93% of the voting rights of this biotechnology company.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.